Glaucoma Clinical Trials

Find Glaucoma Clinical Trials Near You

24-hour Effect Of Rocklatan Compared With Latanoprost In Open Angle Glaucoma And Ocular Hypertension Patients

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alone in the contralateral eye, dosed daily, 1 drop at night (QD, PM) in adult subjects, at least 18 years of age, with open angle glaucoma (OAG) or ocular hypertension (OHT).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Diagnosis of OHT or mild-to-moderate OAG in both eyes (OAG in one eye and OHT in the fellow eye is acceptable) based on VF, OCT and dilated fundus examination within one year of the screening visit.

⁃ Both eyes must qualify for the study with an IOP of ≥18 mmHg but ≤34 mmHg on history or at the screening visit

⁃ Be able and willing to provide signed informed consent and follow study instructions

⁃ Ability to cooperate with the examinations required for the study and be able to attend all study visits

⁃ If a contact lens wearer, willing to remove contact lenses at least 24 hours prior to each of the study visits.

⁃ Best-corrected visual acuity (BCVA) using ETDRS chart of +0.4 logMAR units (Snellen equivalent \

• 20/50) or better in each eye

Locations
United States
Minnesota
Mayo Clinic in Rochester
RECRUITING
Rochester
Contact Information
Primary
Bridgette Halder
Halder.Bridgette@mayo.edu
507-422-2780
Time Frame
Start Date: 2025-11-21
Estimated Completion Date: 2027-10
Participants
Target number of participants: 30
Treatments
Experimental: netarsudil-latanoprost arm
Active_comparator: latanoprost arm
Sponsors
Leads: Mayo Clinic
Collaborators: Alcon Research

This content was sourced from clinicaltrials.gov